Seemingly some lower priced imports POTUS Trump does like:
In an executive order yesterday he paved the way for the importation of medicines from countries where they are cheaper, in a direct move against Big Pharma that often charges US customers around three times the lowest prices levied outside the USA.
This will surely be a popular move, but not with the Pharma sector, which (one must conclude) have done too little to seek favour at the Court of the Tangerine Tyrant.
It seems that all the idiots in the US have learned nothing in the last 40 years, nothing at all.
Look within, and ask yourselves why administering and paying for healthcare costs so much in the US, or why US patients are being billed with medical expenses to begin with?
Why do you think the people in charge don't want to start a domestic source of pharmaceutical manufacturing? It costs too much all around.
They tell us they don't want tariffs. And yet, nobody high up in the business supply chain either domestic or foreign has the temerity to go up against President Trump and call him out on his garbage.
Who was in favor of PNTR with China, India, etc? All the major companies were including the pharmaceutical ones at the time, and much of Congress.
What a terrible, no good idea that MarketWatch's op-ed writers have today. They literally have nothing else, other than to ask about domestic production of pharmaceuticals:
One reason why the U.S. spends far more on healthcare than any other wealthy nation, yet has among the lowest life expectancy, highest infant mortality, and poorest health outcomes among those same nations.
For decades, American Big Pharma has been scheming to undermine Australia’s Pharmaceutical Benefits Scheme (PBS), which has given Australians access to some of the cheapest medicines in the developed world. Their goal? Higher profits at the expense of affordable healthcare. They’d love to see Australia adopt a US-style privatised system, where individuals are forced to pay exorbitant prices for the same medicines we get for just a few dollars.
#BigPharma #PBS #AffordableHealthcare #Australia #Medicare #HealthcareForAll #PharmaGreed #PublicHealth #Auspol #LNPfail
Splash away, I say. Splash away...
________________________
#AusPol #Healthcare #Media #Sky #Murdoch #Pharmaceuticals #BigPharma (can get forked)
Here's what I think. They want this #tech abandoned "because" it is so promising.
If we have a cheap cure / #vaccine for most #cancer, who loses the most?
#BigPharma, that's who.
But if it's abandoned & quietly repackaged & sold to Big Pharma....
"The American Economic Liberties Project today released new research showing that at least 326 U.S. pharmacies have closed since Dec. 19, 2024, when Congress abandoned bipartisan, bicameral PBM reforms as part of a stopgap spending bill. The new data comes ahead of a vote in Congress tomorrow on a continuing resolution to fund the government, where the policymakers could include much-needed structural PBM reform.
“Despite later admitting that he does not know what a pharmacy benefit manager (PBM) is, Elon Musk successfully tanked PBM reforms with nearly unanimous House support late last year,” said Emma Freer, Senior Policy Analyst for Healthcare at the Economic Liberties Project. “As predicted, without Congressional intervention, the Big Three PBMs have continued to abuse their market power, squeezing at least 326 pharmacies – 237 of them independent – out of business in fewer than 10 weeks and stranding their most vulnerable patients in pharmacy deserts without access to lifesaving care. Given these high stakes, it is critical that Congress stand up to these healthcare monopolist middlemen and pass structural PBM reforms that will save their constituents’ time, money, and lives.”
#USA Musk #DOGE #PBMs #BigPharma #Healthcare #Oligopolies #Competition #Antitrust
With all the respect @rms, but RFK jr. is FOR savety testing, NOT anti-vax. That's why he's arguing (unlike you) against #BigPharma and their corruption. Of course you won't read that in the guardian, but you could learn all about at Michel Chossudovsky's independent news outlet...
https://globalresearch.ca
btw: Could you help me please with textile colors on this portrait? (all reference photos been bnw)
Sincerely,
Hugo
@ChristosArgyrop Apropos of this, Christos, why aren't pharma stocks tanking? My premise would be that much of #BigPharma's capital is devoted to collecting economic rents off our regime of prohibitive drug regulation — specifically, the immense costs of registration trials. Why wouldn't the undermining of a stable [scientific] basis for FDA also undermine the valuations of these companies?
@petergleick Not fossil fuels 
How can an economy run without #cars and #emissions? It'll lead to the loss of millions of jobs in #bigoil, #weightloss, #bigpharma and #healthcare industries.
And without all the grants our politicians get from these industries we can't build more roads and cars. It'll lead to #anarchy.
Some (more) proof that Big Pharma (here the example of AstraZenica) is one of the most profitable sectors in the global economy, because they are highly adept at playing one country off against another to get them to bid 'support' to facilitate investments, then the quotes in this piece from Pascal Soriot should furnish that;
He all but admits explicitly that this is what is going on!
Just more corporate welfare dignified by the mechanism of 'competition'
#BigPharma
https://www.theguardian.com/business/2025/feb/06/astrazeneca-reports-38-jump-in-pre-tax-profits-to-87bn
Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's by Charles Piller, 2025
For readers of Empire of Pain and Dopesick, an arresting deep dive into how Alzheimer's disease treatment has been set back by corrupt researchers, negligent regulators, and the profit motives of Big Pharma.
So AstraZenica are not going ahead with the expansion of one of its plants because the offer of state aid from Rachel Reeves was less than Jeremy Hunt offered last year.
If you wondered how BigPharma became one of the most profitable sectors in the global economy it is in least part through a very effective game of corporate welfare acquisition via implied threats to health services.
Still I'm sure they'll mobilise patient groups to blame Reeves!
@autonomysolidarity
Vermutlich haben seine #Oligarchen -Kumpels von #BigPharma + aus dem #Datenkraken -Business ( #Google #Meta #X usw.) ihm gesteckt, dass sie diese Daten gern möglichst vollständig hätten...
Once again - yet again - AGAIN: as of right now, there is no such thing as artificial intelligence outside the realm of science fiction. This is a news article about *algorithm-driven* pharmaceutucal drug development. Every journalist that calls these algorithms "AI" is doing tech companies' advertising for them, and is implicated in the harms that result.
https://neurospan.org/ai-driven-drug-clinical-trials-by-year-end-says-googles-hassabis/
#plantemedicin - 
Hvor ville vi være med plantemedicin med mindre indflydelse på #forskning og #viden fra #bigpharma?
Tænk, hvis vi kunne gå ud og plukke vores medicin i grøftekanten eller haven med solid videnskabelig evidens for det i stedet for at skulle på apoteket?
"Pas på planterne! Nogle lægeplanter er helt uskadelige – for andre er der en hårfin grænse mellem, at stofferne virker – eller at du dør af forgiftning."
#medicin #planter
https://www.dr.dk/nyheder/viden/naturvidenskab/plantemedicin-er-ikke-hokus-pokus-her-er-7-planter-der-faktisk-kurerer
"The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.
Staff’s latest report found that the ‘Big 3 PBMs’—Caremark Rx, LLC (CVS), Express Scripts, Inc. (ESI), and OptumRx, Inc. (OptumRx)—marked up numerous specialty generic drugs dispensed at their affiliated pharmacies by thousands of percent, and many others by hundreds of percent. Such significant markups allowed the Big 3 PBMs and their affiliated specialty pharmacies to generate more than $7.3 billion in revenue from dispensing drugs in excess of the drugs’ estimated acquisition costs from 2017-2022. The Big 3 PBMs netted such significant revenues all while patient, employer, and other health care plan sponsor payments for drugs steadily increased annually, according to the staff report.
“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including medications to treat heart disease and cancer,” said FTC Chair Lina M. Khan. “The FTC should keep using its tools to investigate practices that may inflate drug costs, squeeze independent pharmacies, and deprive Americans of affordable, accessible healthcare—and should act swiftly to stop any illegal conduct.”"
Tim Walz just capped prescription copays for Minnesotans at $25. In case Donald wants suggestions for his “concepts of a plan.”
“We’re putting the wellbeing of our people before the profits of big pharma.”
The country needed him. For far more than prescription costs.
